• Return to Headlines

Adamas Pharmaceu is Among the Companies in the Biotechnology Industry with the Best Relative Performance (ADMS , CHRS , NVAX , ALXN , KPTI )

By David Diaz

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at yesterday's price action of all companies in this peer group.

Adamas Pharmaceu (NASDAQ:ADMS ) ranks first with a gain of 8.33%; Coherus Bioscien (NASDAQ:CHRS ) ranks second with a gain of 4.79%; and Novavax Inc (NASDAQ:NVAX ) ranks third with a gain of 4.28%.

Alexion Pharm (NASDAQ:ALXN ) follows with a gain of 4.09% and Karyopharm Thera (NASDAQ:KPTI ) rounds out the top five with a gain of 4.04%.

SmarTrend recommended that subscribers consider buying shares of Coherus Bioscien on January 9th, 2019 as our technology indicated a new Uptrend was in progress when shares hit $11.23. Since that recommendation, shares of Coherus Bioscien have risen 84.1%. We continue to monitor Coherus Bioscien for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: relative performance adamas pharmaceu coherus bioscien novavax inc alexion pharm karyopharm thera